홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo(c)chromen-1-ol

HCID 2978
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
16849-50-6
표준 SMILES
CCCCCc1cc(O)c2c(c1)OC(C)(C)C1CCC(C)=CC21
InChIKey
CYQFCXCEBYINGO-UHFFFAOYSA-N
분자식
C21H30O2
평균 분자량
314.5 g/mol
단동위원소 질량
314.2245802

개요

6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol is a 1-benzopyran.

이름 및 식별자

우선 이름
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo(c)chromen-1-ol
IUPAC
6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
영어명
6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
분자식
C21H30O2
분자량
314.46

이름 및 동의어

DTXSID208596936,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo(c)chromen-1-olRefChem:1073561DTXCID102091086,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol16849-50-66a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-olDelta 9-THCTHC, delta 9.DELTA.1-Tetrahydrocannabinol(-)-.DELTA.9-THC
이름 더 보기
(L)-.delta.1-TetrahydrocannabinolCannabinol, .DELTA.1-tetrahydro-(-)-.DELTA.1-Tetrahydrocannabinol(-)-.DELTA.9-Tetrahydrocannabinol.DELTA.9-trans-TetrahydrocannabinolL-.delta.1-trans-TetrahydrocannabinolL-trans-.delta.9-Tetrahydrocannabinol(+)-?9-THC

데이터베이스 식별자

CAS
16849-50-6
PubChem CID
2978
DTXSID
DTXSID20859693

물성

구조 계산 물성

XLogP
7
극성 표면적
29.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
4
무거운 원자 수
23
형식 전하
0
복잡도
439

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Treatment · 1건

A potentially serious oral ingestion, if recent, should be managed with gut decontamination. In unconscious patients with a secure airway, instill activated charcoal (30 to 100 g in adults, 1 to 2 g/kg in infants) via a nasogastric tube. A saline cathartic or sorbitol may be added to the first dose of activated charcoal. Patients experiencing depressive, hallucinatory or psychotic reactions should be placed in a quiet area and offered reassurance. Benzodiazepines (5 to 10 mg diazepam po) may be used for treatment of extreme agitation. Hypotension usually responds to Trendelenburg position and IV fluids. Pressors are rarely required. (L1712)

Health Effects · 1건

The heightened suggestibility and intensified emotions that hallucinogens create can worsen any pre-existing emotional problems. Physical effects of hallucinogen use include dilated pupils, sweating, insomnia, loss of appetite, tremors; and increased body temperature, heart rate and blood pressure.

Exposure RoutesOral
Toxicity Summary · 1건

The mechanism of action of marinol is not completely understood. It is thought that cannabinoid receptors in neural tissues may mediate the effects of dronabinol and other cannabinoids. Animal studies with other cannabinoids suggest that marinol's antiemetic effects may be due to inhibition of the vomiting control mechanism in the medulla oblongata.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

HS 번호
2932999099

화학 및 산업

약리 정보

Metabolism/MetabolitesHepatic Route of Elimination: Dronabinol and its biotransformation products are excreted in both feces and urine. Half Life: Alpha phase: approximately 4 hours; Beta phase: 25-36 hours

용도 및 제조

UsesFor the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments

관련 반응

6건
반응 기록 만들기
HRID 166472 반응식
HRID 166472반응물로
HRID 267335 반응식
HRID 267335반응물로
HRID 267340 반응식
HRID 267340반응물로
HRID 2398880 반응식
HRID 2398880반응물로
HRID 2398882 반응식
HRID 2398882반응물로
HRID 2398886 반응식
HRID 2398886반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
ChEBI
CHEBI:143723
Nikkaji
J280.524C